| abstract |
The present invention relates to novel compositions comprising magnolol and/ or honokiol and at least one additional component e.g. selected from ligustilide, oleuropein (I), oleuropein aglycone (II), hydroxytyrosol, rosehip, genistein, resveratrol, EGCG, cashew fruit extract and Glycyrrhiza foetida as well as to the use of these compositions as a medicament, in particular as a medicament for the treatment, co-treatment or prevention of inflammatory disorders. |